gms | German Medical Science

G-I-N Conference 2012

Guidelines International Network

22.08 - 25.08.2012, Berlin

Guideline derived performance measures: what do guideline and performance measure developers need from each other?

Meeting Abstract

Search Medline for

  • T. Stokes - National Institute for Health and Clinical Excellence (NICE), Manchester, UK
  • M. Nothacker - Agency for Quality in Medicine (AZQ), Berlin, Germany
  • M. Nix - Agency for Healthcare Research and Quality (AHRQ), Rockville, US
  • G. Leng - National Institute for Health and Clinical Excellence (NICE), Manchester, UK

Guidelines International Network. G-I-N Conference 2012. Berlin, 22.-25.08.2012. Düsseldorf: German Medical Science GMS Publishing House; 2012. DocPS05

doi: 10.3205/12gin017, urn:nbn:de:0183-12gin0172

Published: July 10, 2012

© 2012 Stokes et al.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( You are free: to Share – to copy, distribute and transmit the work, provided the original author and source are credited.



Background: The need to improve health care quality has led health care systems to adopt quality improvement programmes including pay for performance. A crucial component of quality improvement is the construction and use of performance measures (PMs) that measure clinical quality, health outcomes and patient perspectives. PMs are increasingly being developed explicitly from clinical guideline (CG) recommendations.

Objectives/Goal: To summarize the experiences of different national CG and PM developers on guideline derived PM development and to make recommendations on best practice.

Target group, suggested audience: CG, PM Developers

Moderator: Gillian Leng, National Institute for Health and Clinical Excellence (NICE), UK Deputy Chief Executive

Speaker 1: Tim Stokes, NICE Clinical Lead, national programme of guideline derived PMs (QOF/COF)

Speaker 2: Monika Nothacker, Agency for Quality in Medicine, Germany Lead, PM development in national guidelines

Speaker 3: Mary Nix, Agency for Healthcare Research and Quality, US Lead, national resource of PM in use

Description of session and speaker topics: The session will comprise of three 20 minute presentations followed by 30 minutes of facilitated discussion. S1 and S2 will give a summary of the experiences with UK and German national initiatives and methods in guideline derived PMs, including updating PMs from CGs. S3 will give an overview of US national PM initiatives with a focus on the National Quality Measures Clearinghouse (NQMC). The discussion will cover criteria to assess the quality of guideline derived PMs.